| Nov 21 |
Takeda and Alloy Therapeutics partner to make off-the-shelf CAR-T therapies
|
| Nov 20 |
Takeda in deal with Alloy Therapeutics to develop cell therapy platforms for cancer
|
| Nov 13 |
Why this major drugmaker no longer has an ‘IT department’
|
| Nov 12 |
Urgency, Debate Mark COP29 As Leaders Push For Carbon Market Rules, Worry About Trump
|
| Nov 4 |
New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD
|
| Nov 1 |
Takeda Pharmaceutical Company Limited 2025 Q2 - Results - Earnings Call Presentation
|
| Nov 1 |
Takeda Pharmaceutical Company Limited (TAK) Q2 2025 Earnings Call Transcript
|
| Oct 31 |
HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA® (fruquintinib) Sales by Takeda
|
| Oct 31 |
Takeda Pharmaceutical reports H1 results, revises FY forecast
|
| Oct 31 |
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
|
